Pfizer Chesterfield Addition-Renovation
Chesterfield, Missouri
Our team is proud to bring our clients the lessons learned from executing complex Life Sciences projects. Decades of shared experience in the industry have led to a finely curated project execution plan, which is a playbook for the project. This foundational element is core to the way we plan and execute work, ensuring that all parties are aligned on their roles and responsibilities.
The Clayco Life Sciences team can execute in many different ways, including Design-Bid-Build, Design Build, EPC, Construction Management, and can be flexible depending on your specific needs. Our team will customize and right-size an approach for your specific needs.
Clayco’s delivery model runs engineering, construction and validation in parallel to compress timelines and reduce cost risk in ways the industry has not seen before.
Chesterfield, Missouri
Boulder, Colorado
St. Louis, Missouri
Chesterfield, Missouri
St. Louis, Missouri
St. Charles, Missouri
Creve Coeur, Missouri
Monroe County, Pennsylvania
Mooresville, Indiana
Pleasant Prairie, Wisconsin
St. Louis, Missouri
St. Louis, Missouri
Kansas City, Missouri
Allegheny County, Pennsylvania
St. Louis, Missouri
Fayetteville, Arkansas
St. Louis, Missouri
Livonia, Michigan
Greenville, South Carolina
Shawnee, Kansas
We deliver life sciences work primarily through design-build, EPCM, and integrated iEPCV delivery, and increasingly as an integrated partner across a portfolio rather than project by project. Design-build fits when scope definition is far enough along to carry a guaranteed maximum price, with the exclusions register and equipment pricing basis attached as contract exhibits. EPCM fits when you hold direct contracts with process equipment vendors and want engineering, procurement and construction managed against your own agreements. For regulated production space we recommend iEPCV, which folds verification into the delivery sequence rather than appending it at the end, and for owners with recurring capital we run the same team across a program so procurement leverage, design reuse and lessons learned carry forward. Development, financing, site selection and asset management sit alongside these if you need them. The more consequential decision is timing rather than form: the delivery method should be settled before the Basis of Design is fixed, because that is when the construction sequence and the Critical Design Elements get set.
In a regulated facility, finishing construction and being ready for licensure are two different milestones, and what separates them is documentation. Licensure depends on a traceable record linking design intent to verified performance, where something as small as a missing material certification or an unsigned weld log can hold a facility back for months. Integrated delivery closes that gap by treating verification as continuous work rather than a final inspection, so engineering, construction and verification progress together and the facility arrives ready for performance qualification and process validation. Establishing that discipline is exactly what we were brought in to do on a $1B+ API manufacturing program that was already in construction.
We deliver commissioning and structured turnover. Qualification execution and process validation stay with you and your CQV agent, and our responsibility is that every system arrives complete, documented, and on the date the qualification sequence needs it. Our integrated commissioning and qualification approach follows ASTM E2500: process user requirements are separated from general user requirements so full Quality Unit rigor is applied where product quality is actually at stake, Critical Design Elements are identified during conceptual and basic design, and qualified vendor factory acceptance test data feeds the traceability matrix rather than being repeated onsite as formal IQ/OQ. Mechanical completion is achieved system by system, with staged walkdowns and turnover of each system as it finishes. One condition is worth naming: the risk-based path requires an integrated design basis. Without one, a project defaults to fully sequential IQ/OQ/PQ, which is the slowest and most expensive route available.
For a facility of moderate scale, 24 to 36 months from concept to GMP-ready is a realistic planning range, and conversions of existing space can move faster than that. Recent comparables include a $60M aseptic fill-finish facility at 24 months, a $70M conversion within an operating facility at 24 months, and a smaller $15M conversion at 12 months. Greenfield large-molecule programs sit at the long end, since both utility infrastructure and qualification scope grow with the modality. The three variables that move the number most are how well the process is defined at authorization, equipment lead times, and the depth of qualification your product requires, so we would rather build the duration from your scope than hand you a benchmark.
iEPCV stands for Integrated Engineering, Procurement, Construction and Verification. Validation practice has already moved toward risk-based, iterative methods under ASTM E2500 and the FDA’s computer software assurance framework, but conventional EPC still runs on sequential phase gates, so verification collects at the end as a spike in effort and paperwork at precisely the point in the schedule with the least room for it. iEPCV breaks the work into smaller packages and aligns them with the verification sequence, so systems are verified as they become available instead of all at once. The practical difference is that compliance is built in along the way rather than assembled afterward.
The difference is that the facility has to be provable, not just built. Every material certification, weld log and test record becomes part of the evidence package supporting licensure, so field documentation is production work rather than paperwork that follows it, and a single missing certification can hold a facility back for months. The physical requirements follow from the same logic: classified space drives airtightness, seamless finishes, sealed penetrations and controlled construction protocols in areas that are still active job sites, while process utilities such as WFI, clean steam and process gas make mechanical and electrical the dominant scope rather than a supporting one. Design is also equipment-led, so vendor selection and factory acceptance testing sit on the critical path in a way they do not on conventional projects, and work inside an operating plant is governed by shutdown windows and tie-in access instead of construction duration. The practical consequence is that commissioning and qualification have to be planned as first-order work from the start, and that the field team needs genuine sector depth, because quality expectations have to be present in daily execution rather than introduced at turnover.
Most of the available time is won before construction starts. Engaging the builder before the RFP goes out, and at the Basis of Design stage at the latest, is what allows the construction sequence and the Critical Design Elements to be set once rather than renegotiated later as change orders. From there, the largest single lever is a risk-based verification approach under ASTM E2500: separating process user requirements from general user requirements so full Quality Unit rigor lands only where product quality is at stake, and accepting qualified vendor factory acceptance test data as primary evidence instead of repeating it onsite as formal IQ/OQ. That matters because validation teams working the traditional way have historically spent roughly 80 percent of their effort on documentation and 20 percent on testing. In parallel, procurement and permitting need to be treated as schedule, not administration, with the schedule-driving purchase orders released at award ahead of full buyout, alternate vendors qualified during bidding, and permits tracked as long-lead items, since an air quality permit for a dust collection system can take 60 to 180 days. Finally, sequencing mechanical completion system by system with staged walkdowns and turnover lets qualification begin on early systems while later ones are still in construction. None of this trades away compliance, but all of it depends on an integrated design basis with documented risk justification; without one, the project defaults to fully sequential IQ/OQ/PQ, which is the slowest route available.
Earlier than most owners expect: before the RFP goes out, and at the Basis of Design stage at the latest. That is when the construction sequence and the Critical Design Elements get set, and both shape cost, schedule and qualification scope from that point on. Engaging a builder after the specification package is fixed usually means GMP requirements that were never priced surface later as change orders. It is also worth testing how defined the scope truly is before committing to a contract form, since a package at 60 percent drawings is often less integrated than the percentage suggests.
They are frequently the critical path, ahead of construction itself. On current work we are carrying roughly 30 weeks for a single air handling unit, about 16 weeks from purchase order to mezzanine steel on site, and 13 to 18 weeks for electrical distribution gear and transformers, with owner-furnished process equipment running about three months per line through factory acceptance testing and shipping. Permits deserve the same treatment as equipment, since an air quality construction permit for a dust collection system can take 60 to 180 days to review. We manage it by releasing the schedule-driving purchase orders at award ahead of full buyout, qualifying alternate vendors during the bid phase, and carrying delivery milestones and their float on the schedule so the exposure stays visible rather than assumed.
On a current multi-line project, qualification runs roughly five months per line, staggered across the lines. It compresses in two ways: applying full Quality Unit rigor only to the requirements that genuinely affect product quality, and accepting qualified vendor factory acceptance test data as primary evidence instead of repeating those tests onsite as formal IQ/OQ. There is real room to recover, since validation teams working the traditional way have historically spent about 80 percent of their effort on documentation and only 20 percent on testing. What makes that compression available is an integrated design basis with documented risk justification, which means the decision about C&Q duration is effectively made during design.
Estimates vary because scope definition varies, not because estimators disagree. AACE guidance puts a Class 3 pharmaceutical estimate at roughly minus 10 to 25 percent on the low side and plus 20 to 50 percent on the high side at about 80 percent confidence, and a Class 4 estimate is wider still. Rather than take a drawing percentage at face value, we score the underlying scope definition, because a package can look more finished than the decisions behind it are. Our guidance is to set design contingency to the estimate class you actually have, and where definition is still developing, use a guaranteed maximum price with the exclusions register and equipment pricing basis attached as contract exhibits so the remaining risk is visible to both parties.
Retrofit usually wins on cost and speed when the existing envelope, utility capacity and floor-to-floor can carry the process. The trade is that your schedule is then governed by shutdown windows rather than construction duration. On a current 81,000 square foot expansion inside a plant running five days a week, the whole project turns on an eight-week shutdown, of which about two weeks belong to commissioning and qualification, leaving roughly six weeks of construction access across 25 utility tie-ins. Greenfield buys clean sequencing and no risk to product in production, at the cost of time, land and complete utility infrastructure. The question that usually settles it is how much of your existing utility capacity is truly available, and that is worth surveying before either option gets priced.
On the capital delivery side, the tradeoff comes down to load factor. For a program of roughly $100M a year, per-project delivery typically requires around 16 owner positions where an integrated partner program needs about six, which is close to $2M a year in avoided internal cost. Adding procurement speed, bulk buying leverage, reduced change and rework, design reuse and consolidated overhead, we model total value at about 9 percent of annual capital spend once the program reaches run rate. The partner fee is a visible premium on professional services, measured in single-digit percentages, while the savings are measured against total capital spend. Building the capability internally makes sense when your volume and project cadence can keep a specialized team continuously loaded, and below that threshold you end up carrying capability you cannot fully use.
Site selection sets three things that govern your schedule before construction even starts: permitting jurisdiction, utility availability, and local craft depth. Permitting alone can decide a date, with building permit review commonly running about seven weeks, air quality permits for dust collection taking 60 to 180 days including public notice, and trade permits often expiring in 90 to 120 days, which forces phased pulls on longer builds. Utility capacity at the property line and the complexity of tie-ins frequently matter more to total schedule than land cost does. We evaluate candidate sites against those criteria, alongside development, financing and asset management support.
Three come up consistently. Procurement and sequencing set the schedule far more than manpower does, and the programs that hold their dates are the ones that released long-lead electrical and mechanical packages early and brought trade partners in before design closed. Life sciences quality expectations have to be present in daily field execution from the start rather than introduced at turnover, which is why sector depth in the field team matters as much as it does in the office. And commissioning and qualification have to be planned as first-order work, with completion defined by system readiness and quality records instead of physical progress. A quieter fourth lesson is that lessons only compound when the same team carries them from one project to the next.
The API, fill-finish and biologics capacity being committed in the US is arriving largely at once, and it draws on the same specialty trades, equipment vendors and CQV resources that every program needs. It shows up in estimates before it shows up in headlines: longer equipment lead times, escalation in the 4 to 6 percent range, and craft availability in secondary markets becoming a scheduled risk rather than a background assumption. Owners who commit early and lock procurement at award are absorbing less of that pressure than those still bidding project by project. Where federal or state funding participates, prevailing wage, Buy American and reporting obligations add a further layer that affects both cost and vendor selection.
Established local relationships, early commitment, and self-perform capability as a backstop. In markets where we build repeatedly, Lincoln among them, we have worked with the same trade contractors for a decade, and that continuity is what makes manpower forecasts and pricing dependable when the market is tight. We commit trades at award and share a resource-loaded schedule with them so their planning is built on the same dates ours is. We also self-perform several of the trades that drive early schedule, including concrete and cGMP-grade resinous flooring, process and equipment rigging, and bulk commodity procurement through our own purchasing group, so the work that sets the critical path is not fully dependent on market availability.